Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: Highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 185-194

  Arsalani, Nasser ^a   Fattahi, Hassan ^a,b   Laurent, Sophie ^b   Burtea, Carmen ^b   Elst, Luce Vander ^b   Muller, Robert N ^b  

^a UNIVERSITY OF TABRIZ   (Iran)

^b UNIVERSITY OF MONS   (Belgium)

Author keywords

Contrast agent; Iron oxide nanoparticles; Molecular imaging; MRI; Nanomedicine; Polyglycerol; Superparamagnetism

Indexed keywords

GLYCIDOL; MOLECULAR SCAFFOLD; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; CALCULATION; IN VIVO STUDY; KIDNEY SCINTISCANNING; LIVER SCINTISCANNING; MAGNETIC FIELD; MAGNETOMETRY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; PRIORITY JOURNAL; RING OPENING METATHESIS POLYMERIZATION; URINARY EXCRETION;

ANIMALS; CONTRAST MEDIA; DEXTRANS; GLYCEROL; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETICS; MAGNETITE NANOPARTICLES; MICE; MOLECULAR IMAGING; NANOPARTICLES; PARTICLE SIZE; PHANTOMS, IMAGING; POLYMERS; SILANES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84858732013     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.479     Document Type: Article

References (48)

1. Rinck PA. Magnetic Resonance in Medicine. Wiley Blackwell: Berlin, 2003.
2. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 2011; 32: 1890-1905.
3. Terreno E, Castelli DD, Viale A, Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010; 110: 3019-3042.
4. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
5. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH, Deleij L. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992; 25: 148-157.
6. Fattahi H, Laurent S, Liu F, Arsalani N, Vander Elst L, Muller RN. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. Nanomedicine 2011; 6(3): 529-544.
7. Cormode DP, Jarzyna PA, Mulder WJM, Fayad ZA. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev 2010; 62: 329-338.
8. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16: 4712-4727.
9. Sun C, Du K, Fang C, Bhattarai N, Veiseh O, Kievit F, Stephen Z, Lee D, Ellenbogen RG, Ratner B, Zhang M. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 2010; 4: 2402-2410.
10. Liu F, Laurent S, Fattahi H, Vander Elst L, Muller RN. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. Nanomedicine 2011; 6(3): 519-528.
11. Fan C, Gao W, Chen Z, Fan H, Li M, Deng F, Chen Z. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Int J Pharm 2011; 404: 180-190.
12. Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release 2011; 149: 314-322.
13. Renard P-E, Lortz R, Senatore C, Rapin J-P, Buchegger F, Petri-Fink A, Hofmann H, Doelker E, Jordan O. Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silicamicro particles for magnetically induced local hyperthermia. J Magn Magn Mater 2011; 323: 1054-1063.
14. Chen F, Shi R, Xue Y, Chen L, Wan Q-H. Templated synthesis of monodisperse mesoporous maghemite/silica microspheres for magnetic separation of genomic DNA. J Magn Magn Mater 2010; 322: 2439-2445.
15. Burtea C, Laurent S, Mahieu I, Larbanoix L, Roch A, Port M, Rousseaux O, Ballet S, Murariu O, Toubeau G, Corot C, Vander Elst L, Muller RN. In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media Mol Imag 2011; 6(4): 236-250.
16. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M. Long-circulating iron oxides for MR imaging. Adv Drug Deliv Rev 1995; 16: 321-334.
17. Kaim AH, Wischer T, Reilly T, Jundt G, Frohlich J, Schulthess GK, Allegrini PR. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 2002; 225: 808-814.
18. Lacava LM, Lacava ZG, Silva MF, Silva O, Chaves SB, Azevedo RB, Pelegrini F, Gansau C, Buske N, Sabolovic D, Morais PC. Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J 2001; 80: 2483-2486.
19. Lin H, Watanabe Y, Kimura M, Hanabusa K, Shirai H. Preparation of magnetic poly(vinyl alcohol) (PVA) materials by in situ synthesis of magnetite in a PVA matrix. J Appl Polym Sci 2003; 87: 1239-1247.
20. Lee SJ, Jeong JR, Shin SC, Kim JC, Chang YH, Lee KH, Kim JD. Magnetic enhancement of iron oxide nanoparticles encapsulated with poly( d, l-latide-co-glycolide). Colloids Surf A 2005;255:19-25.
21. Kohler N, Sun C, Fichtenholtz A, Gunn J, Fang C, Zhang MQ. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006; 2: 785-792.
22. 4 nanoparticles for biomedical applications. J Magn Magn Mater 2007; 310: 815-817.
23. 4 nanoparticles as an MRI contrast agent. eXPRESS Polym Lett 2010; 4: 329-338.
24. Lee H, Lee E, Kim DK, Jang NK, Jeong YY, Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 2006; 128: 7383-7389.
25. 4/APTES/PEG diacid functionalized magnetic nanoparticles for MR imaging. Colloid Surf A 2008; 328: 52-59.
26. Barrera C, Herrera AP, Rinaldi C. Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol). J Colloid Interf Sci 2009; 329: 107-113.
27. 4/amino-silane core shell nanoparticles via layer-by-layer method. Appl Surf Sci 2009; 225: 7974-7980.
28. Kautz H, Sunder A, Frey H. Control of the molecular weight of hyperbranched polyglycerols. Macromol Symp 2001; 163: 67-73.
29. Liu Z, Janzen J, Brooks DE. Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells. Biomaterials 2010; 31(12): 3364-3373.
30. Calderon M, Graeser R, Kratz F, Haag R. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. Bioorg Med Chem Lett 2009; 19: 3725-3728.
31. Calderon M, Warnecke A, Graser R, Haag R, Kratz F. Development of enzymatically cleavable doxorubicin conjugates with polyglycerol. J Control Release 2008; 132: e54-e55.
32. Gottschalk C, Wolf F, Frey H. Multi-arm star poly ( l-lactide) with hyperbranched polyglycerol core. Macromol Chem Phys 2007; 208: 1657-1665.
33. 4 nanoparticles as novel magnetic resonance imaging contrast agent: an in vitro assessment. Adv Func Mater 2009; 19: 2615-2622.
34. Massart R, Cabuil V. Effect of some parameters on the formation of colloidal magnetite in alkaline medium: yield and particle size control. J Chem Phys 1987; 84: 967-973.
35. Burtea C, Laurent S, Vander Elst L, Muller RN. Contrast agents: magnetic resonance. Handb Exp Pharmacol 2008; 185: 135-165.
36. 4 magnetic nanoparticles. Desalination 2010; 254: 162-169.
37. Forge D, Gossuin Y, Roch A, Laurent S, Vander Elst L, Muller RN. Development of magnetic chromatography to sort polydisperse nanoparticles in ferrofluids. Contrast Media Mol Imag 2010; 5: 126-132.
38. Flesch C, Delaite C, Dumas P, Bourgeat-Lami E, Duguet E. Grafting of poly(ε-caprolactone) onto maghemite nanoparticles. J Polym Sci Pol Chem 2004; 42: 6011-6020.
39. Heiney PA, Gruneberg K, Fang J, Dulcey C, Shashidhar R. Structure and growth of chromophore-functionalized (3-aminopropyl) triethoxysilane self-assembled on silicon. Langmuir 2000; 16: 2651-2657.
40. Abdel-Hameed SAM, Hessien MM, Azooz MA. Preparation and characterization of some ferromagnetic glass-ceramics contains high quantity of magnetite. Ceram Int 2009; 35: 1539-1544.
41. Basly B, Felder-Flesch D, Perriat P, Billotey C, Taleb J, Pourroy G, Begin-Colin S. Dendronized iron oxide nanoparticles as contrast agents for MRI. Chem Commun 2010; 46: 985-987.
42. Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 1999; 110: 5403-5411.
43. Roch A, Gillis P, Ouakssim A, Muller RN. Proton relaxation in superparamagnetic aqueous colloids: a new tool for the investigation of ferrite crystal anisotropy. J Magn Magn Mater 1999; 201: 77-79.
44. Ouakssim A, Fastrez S, Roch A, Laurent S, Gossuin Y, Pierart C, Vander Elst L, Muller RN. Control of the synthesis of magnetic fluids by relaxometry and magnetometry. J Magn Magn Mater 2004; 1711: 272-276.
45. Radermacher KA, Beghein N, Boutry S, Laurent S, Vander Elst L, Muller RN, Jordan BF, Gallez B. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin. Invest Radiol 2009; 44: 398-404.
46. Thunemann AF, Schutt D, Kaufner L, Pison U, Mohwald H. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid). Langmuir 2006; 22: 2351-2357.
47. 2 nanoparticles for targeting ovarian cancer cells. Biomaterials 2011; 32: 2166-2173.
48. Weinhart M, Grunwald I, Wyszogrodzka M, Gaetjen L, Hartwig A, Haag R. Linear poly(methyl glycerol) and linear polyglycerol as potent protein and cell resistant alternatives to poly(ethylene glycol). Chem Asian J 2010; 5(9): 1992-2000.